[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343779-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-343779-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","systematic-literature-review-on-the-clinical-and-economic-burden-of-human-papillomavirusrelated-diseases-in-select-areas-in-the-asia-pacific-region","Systematic literature review on the clinical and economic burden of human papillomavirus–related diseases in select areas in the Asia-Pacific region","","Compared with Europe and America, adoption of human papillomavirus (HPV) vaccination in national immunization programs across the Asia-Pacific (AP) region has remained low, and HPV burden there has not been comprehensively reviewed. This systematic literature review summarized the clinical and economic burden of HPV and HPV-related diseases in select AP areas. Searches covered January 2000 to February 2022 using MEDLINE/Embase, including adult observational studies reporting incidence, prevalence, costs, or HCRU. Among 254 publications, reported incidence and prevalence varied widely and few studies addressed costs or HCRU. Findings indicate high burden and support improved screening, education, vaccine-hesitancy reduction, and better data collection to inform policy and monitoring.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/systematic-literature-review-on-the-clinical-and-economic-burden-of-human-papillomavirusrelated-diseases-in-select-areas-in-the-asia-pacific-region/343779/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/systematic-literature-review-on-the-clinical-and-economic-burden-of-human-papillomavirusrelated-diseases-in-select-areas-in-the-asia-pacific-region/343779.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of this systematic literature review?","Question",{"text":63,"@type":64},"The review summarizes the clinical and economic burden of human papillomavirus (HPV) and HPV-related diseases in selected Asia-Pacific areas, where vaccination adoption and burden assessment have not been comprehensively reviewed.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What time period and databases were used for the literature search?",{"text":68,"@type":64},"An SLR was conducted from January 2000 to February 2022 using MEDLINE and Embase, including observational studies reporting incidence, prevalence, costs, or healthcare resource utilization.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the results show about incidence and prevalence across cancer types?",{"text":72,"@type":64},"Reported incidence and prevalence varied by cancer site, with incidence per 100,000 person-years ranging substantially for cervical, head and neck, and anal cancers, and prevalence also showing wide ranges across multiple HPV-related cancers.",{"name":74,"@type":61,"acceptedAnswer":75},"Why do the authors emphasize improved data collection in data-scarce areas?",{"text":76,"@type":64},"Because few studies reported costs or healthcare resource utilization and high data variability was observed, improved data collection is needed to better inform policy decisions and monitor the impact of HPV vaccination.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},343779,1790793118,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":116,"preview_page_count":33,"preview_urls":149},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","HUMAN VACCINES & IMMUNOTHERAPEUTICS 2024, VOL. 20, NO. 1, 2425535 [https://doi.org/10.1080/21645515.2024.2425535](https://doi.org/10.1080/21645515.2024.2425535)  \nRESEARCH ARTICLE     \nSystematic literature review on the clinical and economic burden of human papillomavirus–related diseases in select areas in the Asia-Pacific region  \nPei-Jen Loua, Wanatpreeya Phongsamartb, Isaya Sukaromc, Ying-Hui Wud, Omer Zaidie, Frieda Duf, Alyssa Simone, and Mark Bernauere  \naDepartment of Otolaryngology, National Taiwan University Hospital and College of Medicine, Taipei City, Taiwan; bDepartment of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand; cOutcomes Research, Asia Pacific, MSD Thailand, Bangkok, Thailand; dGlobal Medical and Scientific Affairs, MSD Taiwan, Taipei, Taiwan; e Evidence & Access, OPEN Health, Bethesda, MD, USA; fEvidence & Access, OPEN Health, Shanghai, China  \nABSTRACT  \nCompared with Europe and America, adoption of human papillomavirus (HPV) vaccination into national immunization programs across the Asia-Pacific (AP) region has remained low. Moreover, HPV burden in this region has not been reviewed comprehensively. Therefore, this systematic literature review (SLR) aimed to summarize the clinical and economic burden of HPV and HPV-related diseases in select AP areas. An SLR was conducted January 2000-February 2022 using MEDLINE/Embase. Observational studies reporting incidence, prevalence, costs, or healthcare resource utilization (HCRU) of HPV and HPVrelated disease among adults (≥18 years) from select AP areas were included. A total of 254 publications were included. Reported incidence per 100,000 person-years was 15.4–252.0 for cervical cancer (n = 5 publications), 0.2–55.5 for head and neck cancer (n = 7 publications), and 0.2–13.7 for anal cancer (n = 4 publications) . Prevalence rates were 9.1%-100% for cervical cancer (n = 40 publications), 0.0%-95.6% for head and neck cancer (n = 48 publications), 0.0%-100% for anal cancer (n = 4 publications), 36.0%-79.6% for penile cancer (n = 4 publications), and 44.0%-82.0% for vaginal/vulvar cancer (n = 3 publications) . Few studies reported on costs or HCRU, and high data variability was observed. Despite data variability, the high burden of HPV and HPV-related diseases makes clear the need for effective HPV screening, greater education, and reductions in vaccine hesitancy, particularly among lower- and middle-income areas. Improved data collection measures should be considered in data-scarce areas to better inform policy decision-making and improve monitoring of the impact of HPV vaccination.  \nARTICLE HISTORY  \nReceived 26 June 2024 Revised 15 October 2024 Accepted 1 November 2024  \nKEYWORDS  \nAsia Pacific; cost; genotype; healthcare resource utilization; human papillomavirus; incidence; prevalence  \nIntroduction  \nHuman papillomavirus (HPV) is among the most common sexually transmitted infections globally. 1 There are more than 200 types of HPV, including low-risk types that are associated with genital warts and recurrent respiratory papillomatosisand high-risk oncogenic types that account for most cases of cervical cancer, as well as head and neck, anal, penile, vaginal, and vulvar cancers. 1 Although HPV genotype distribution in cervical cancer/precancer and genital warts has been widely studied,2–6 there is a need for more literature on genotype distribution in other HPV-related cancers.  \nThe incidence and mortality of HPV-related diseases such as cervical cancer are higher in transitioning countries (i.e., those classified as low/medium on the Human Development Index),7 primarily attributable to a relative lack of high-quality screening and timely access to cancer surgery, radiation therapy, and other cancer management services in those countries.8,9 In 2020, the World Health Organization launched a global initiative to eliminate cervical cancer, focusing on the need for high levels of HPV vaccination, screening, and tre","cbCaicro4ldgyv78","https://ap.wps.com/l/cbCaicro4ldgyv78","pdf",2482344,12,"English","# Introduction\n## HPV epidemiology and prevention context\n## Rationale for the review in Asia-Pacific\n# Methods\n## Literature search strategy and study inclusion\n# Results\n## Incidence of HPV-related cancers\n## Prevalence of HPV-related cancers\n## Costs and healthcare resource utilization\n# Discussion\n## Implications for screening, education, and vaccine hesitancy\n## Need for improved data collection and policy monitoring","[{\"question\":\"What is the purpose of this systematic literature review?\",\"answer\":\"The review summarizes the clinical and economic burden of human papillomavirus (HPV) and HPV-related diseases in selected Asia-Pacific areas, where vaccination adoption and burden assessment have not been comprehensively reviewed.\"},{\"question\":\"What time period and databases were used for the literature search?\",\"answer\":\"An SLR was conducted from January 2000 to February 2022 using MEDLINE and Embase, including observational studies reporting incidence, prevalence, costs, or healthcare resource utilization.\"},{\"question\":\"What do the results show about incidence and prevalence across cancer types?\",\"answer\":\"Reported incidence and prevalence varied by cancer site, with incidence per 100,000 person-years ranging substantially for cervical, head and neck, and anal cancers, and prevalence also showing wide ranges across multiple HPV-related cancers.\"},{\"question\":\"Why do the authors emphasize improved data collection in data-scarce areas?\",\"answer\":\"Because few studies reported costs or healthcare resource utilization and high data variability was observed, improved data collection is needed to better inform policy decisions and monitor the impact of HPV vaccination.\"}]","Systematic literature review on the clinical and economic burden of human papillomavirus–related diseases in select areas in the Asia-Pacific region | PDF",1790052086,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6696960bab239b4755689f9c67567470.webp",983,1280,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/104a6a719d0e8e89c4f4483f48391745.webp",982,1278,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/140b77bd76568898d8bcb49bfa321716.webp",981,1277,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4eef610093720f749a76b08554d9a6e7.webp",980,1276]